InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Demitrack Mark, Directeur Médical. Officer active across 1 companies, notably TREVENA INC. Cumulatively, 6 reports have been recorded. The latest transaction was filed on 17 December 2021 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€7,66312,408 shares@ €0.617680.66% mcap30.3% of flow
Common Stock
SEC:0001192482-21-000766·
€7,66312,408 shares@ €0.617680.66% mcap15.2% of flow
Common Stock
SEC:0001192482-21-000766:0·
€17,59530,601 shares@ €0.57569.7% of flow
Common Stock
SEC:0001879785-21-000034·
€17,59530,601 shares@ €0.57534.8% of flow
Common Stock
SEC:0001879785-21-000034:0·
0390,000 shares0
Common Stock
SEC:0001879785-21-000026·
0390,000 shares0
Common Stock
SEC:0001879785-21-000026:0·
6 of 6 declarations
About Demitrack Mark
Mark Demitrack serves as Senior Vice President and Chief Medical Officer of Trevena Inc. In this role, he is responsible for leading the company's medical and clinical activities. Mark plays a key role in developing new treatments and guiding strategic medical decisions. His expertise in medicine and research is essential for the success of Trevena.
